| AGE-RAGE | Advanced glycation end products–receptor for advanced glycation end products |
| AMPK | AMP-activated protein kinase |
| BMD | Bone mineral density |
| BMI | Body mass index |
| CT | Non-osteoporotic controls |
| DEGs | Differentially expressed genes |
| HB | Matched healthy bone |
| HIF-1 | Hypoxia-inducible factor 1 |
| IL-17 | Interleukin 17 |
| IMSS | Mexican Institute of Social Security |
| INMEGEN | National Institute of Genomic Medicine |
| INRLGII | Instituto Nacional de Rehabilitación “Luis Guillermo Ibarra Ibarra” |
| logFC | Log fold-change |
| MAPK | Mitogen-activated protein kinase |
| MHWCS | Mexican Health Worker Cohort Study |
| NF-κB | Nuclear factor kappa B |
| NOD | Nucleotide-binding oligomerization domain |
| OP | Osteoporosis |
| OS | Osteosarcoma |
| PC1 | Principal component 1 |
| PC2 | Principal component 2 |
| PCA | Principal component analysis |
| PI3K-Akt | Phosphoinositide 3-kinase–protein kinase B |
| PPAR | Peroxisome proliferator-activated receptor |
| RNA-seq | RNA sequencing |
| TNF | Tumor necrosis factor |